Background Anterior gradient homolog 2 (AGR2) is a functional protein with critical roles in a diverse range of biological systems, including vertebrate tissue development, inflammatory tissue injury responses, and cancer progression. Clinical studies have shown that the AGR2 protein is overexpressed in a wide range of human cancers, including carcinomas of the esophagus, pancreas, breast, prostate, and lung, making the protein as a potential cancer biomarker. However, the general biochemical functions of AGR2 in human cells remain undefined, and the signaling mechanisms that drive AGR2 to inhibit p53 are still not clearly illustrated. Therefore, it is of great interest to develop molecular probes specifically recognizing AGR2 for its detection and for the elucidation of AGR2-associated molecular mechanism. Methodology/Principal Findings Through a bead-based and flow cytometry monitored SELEX technology, we have identified a group of DNA aptamers that can specifically bind to AGR2 with Kd values in the nanomolar range after 14 rounds of selections. Aptamer C14B was chosen to further study, due to its high binding affinity and specificity. The optimized and shortened C14B1 has special G-rich characteristics, and the G-rich region of this binding motif was further characterized to reveal an intramolecular parallel G-quadruplex by CD spectroscopy and UV spectroscopy. Our experiments confirmed that the stability of the G-quadruplex structure was strongly dependent on the nature of the monovalent ions and the formation of G-quadruplex structure was also important for the binding capacity of C14B1 to the target. Furthermore, we have designed a kind of allosteric molecule beacon (aMB) probe for selective and sensitive detection of AGR2. Conclusion/Significance In this work, we have developed new aptamer probes for specific recognition of the AGR2. Structural study have identified that the binding motif of aptamer is an intramolecular parallel G-quadruplex structure and its structure and binding affinity are strongly dependent on the nature of the monovalent ion. Furthermore, with our design of AGR2-aMB, AGR2 could be sensitively and selectively detected. This aptamer probe has great potential to serve as a useful tool for early diagnosis and prognosis of cancer and for fundamental research to elucidate the biochemical functions of AGR2.
References
[1]
Bradley L, Wainstock D, Sive H (1996) Positive and negative signals modulate formation of the Xenopus cement gland. Development 122: 2739–2750.
[2]
Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, et al. (2006) Prognostic relevance of AGR2 expression in breast cancer. Clinical Cancer Research 12: 1728–1734.
[3]
Riener MO, Pilarsky C, Gerhardt J, Grutzmann R, Fritzsche FR, et al. (2009) Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histol Histopathol 24: 1121–1128.
[4]
Fritzsche FR, Dahl E, Dankof A, Burkhardt M, Pahl S, et al. (2007) Expression of AGR2 in non small cell lung cancer. Histol Histopathol 22: 703–708.
[5]
Zhang JS, Gong A, Cheville JC, Smith DI, Young CYF (2005) AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes & Cancer 43: 249–259.
[6]
Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R (2005) Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Research 65: 3796–3805.
[7]
Kumar A, Godwin JW, Gates PB, Garza-Garcia AA, Brockes JP (2007) Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science 318: 772–777.
[8]
Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, et al. (2004) The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Molecular & Cellular Proteomics 3: 534–547.
[9]
Wang Z, Hao Y, Lowe AW (2008) The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Research 68: 492–497.
[10]
Maslon MM, Hrstka R, Vojtesek B, Hupp TR (2010) A Divergent Substrate-Binding Loop within the Pro-oncogenic Protein Anterior Gradient-2 Forms a Docking Site for Reptin. Journal of Molecular Biology 404: 418–438.
[11]
Schreiber SL (2011) Organic synthesis toward small-molecule probes and drugs. Proc Natl Acad Sci U S A 108: 6699–6702.
[12]
Montagnani M, Marangoni A, Roda A, Azzaroli F, Mazzella G, et al. (2009) Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorption. Mol Pharm 6: 1012–1018.
[13]
Dover JE, Hwang GM, Mullen EH, Prorok BC, Suh SJ (2009) Recent advances in peptide probe-based biosensors for detection of infectious agents. J Microbiol Methods 78: 10–19.
[14]
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505–510.
[15]
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818–822.
[16]
Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clinical Chemistry 45: 1628–1650.
[17]
Shangguan D, Cao ZC, Li Y, Tan W (2007) Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clinical Chemistry 53: 1153–1155.
[18]
Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, et al. (2002) Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 20: 473–477.
[19]
Fang XH, Tan WH (2010) Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach. Accounts of Chemical Research 43: 48–57.
[20]
Osborne SE, Matsumura I, Ellington AD (1997) Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1: 5–9.
[21]
Famulok M, Hartig JS, Mayer G (2007) Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 107: 3715–3743.
[22]
Navani NK, Li Y (2006) Nucleic acid aptamers and enzymes as sensors. Curr Opin Chem Biol 10: 272–281.
[23]
Bunka DH, Stockley PG (2006) Aptamers come of age - at last. Nat Rev Microbiol 4: 588–596.
[24]
Ireson CR, Kelland LR (2006) Discovery and development of anticancer aptamers. Mol Cancer Ther 5: 2957–2962.
[25]
Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Research 62: 4029–4033.
[26]
Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 100: 15416–15421.
[27]
Liu J, Cao Z, Lu Y (2009) Functional nucleic acid sensors. Chem Rev 109: 1948–1998.
[28]
Yang CJ, Jockusch S, Vicens M, Turro NJ, Tan W (2005) Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A 102: 17278–17283.
[29]
Kwon OS, Park SJ, Jang J (2010) A high-performance VEGF aptamer functionalized polypyrrole nanotube biosensor. Biomaterials 31: 4740–4747.
[30]
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545–580.
[31]
Backer MV, Levashova Z, Patel V, Jehning BT, Claffey K, et al. (2007) Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nature Medicine 13: 504–509.
[32]
Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17: 375–378.
[33]
Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 101: 17867–17872.
[34]
Bell SD, Denu JM, Dixon JE, Ellington AD (1998) RNA molecules that bind to and inhibit the active site of a tyrosine phosphatase. Journal Of Biological Chemistry 273: 14309–14314.
[35]
Jenison RD, Jennings SD, Walker DW, Bargatze RF, Parma D (1998) Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion. Antisense Nucleic Acid Drug Dev 8: 265–279.
[36]
Gal SW, Amontov S, Urvil PT, Vishnuvardhan D, Nishikawa F, et al. (1998) Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function. European Journal Of Biochemistry 252: 553–562.
[37]
Blind M, Kolanus W, Famulok M (1999) Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. Proc Natl Acad Sci U S A 96: 3606–3610.
[38]
Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nature Reviews Drug Discovery 9: 537–550.
[39]
Raddatz MS, Dolf A, Endl E, Knolle P, Famulok M, et al. (2008) Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed Engl 47: 5190–5193.
[40]
Tang Z, Shangguan D, Wang K, Shi H, Sefah K, et al. (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Analytical Chemistry 79: 4900–4907.
[41]
Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, et al. (2008) Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 3: 991–1001.
[42]
Shangguan D, Meng L, Cao ZC, Xiao Z, Fang X, et al. (2008) Identification of liver cancer-specific aptamers using whole live cells. Analytical Chemistry 80: 721–728.
[43]
Li Y, Jiang Z, Chen H, Ma WJ (2004) A modified quantitative EMSA and its application in the study of RNA–protein interactions. J Biochem Biophys Methods 60: 85–96.
[44]
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
[45]
Huppert JL, Balasubramanian S (2005) Prevalence of quadruplexes in the human genome. Nucleic Acids Research 33: 2908–2916.
[46]
Rachwal PA, Fox KR (2007) Quadruplex melting. Methods 43: 291–301.
[47]
Paramasivan S, Rujan I, Bolton PH (2007) Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding. Methods 43: 324–331.
[48]
Mergny JL, Phan AT, Lacroix L (1998) Following G-quartet formation by UV-spectroscopy. Febs Letters 435: 74–78.
[49]
Tasset DM, Kubik MF, Steiner W (1997) Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. Journal of Molecular Biology 272: 688–698.
[50]
Shum KT, Tanner JA (2008) Differential Inhibitory Activities and Stabilisation of DNA Aptamers against the SARS Coronavirus Helicase. Chembiochem 9: 3037–3045.
[51]
Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J (1993) Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci U S A 90: 3745–3749.
[52]
Simonsson T (2001) G-quadruplex DNA structures–variations on a theme. Biol Chem 382: 621–628.
[53]
Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006) Quadruplex DNA: sequence, topology and structure. Nucleic Acids Research 34: 5402–5415.
[54]
Davis JT (2004) G-quartets 40 years later: From 5′-GMP to molecular biology and supramolecular chemistry. Angewandte Chemie-International Edition 43: 668–698.
[55]
Song Y, Cui L, Wu J, Zhang W, Zhang WY, et al. (2011) Allosteric molecular beacons for sensitive detection of nucleic acids, proteins, and small molecules in complex biological samples. Chemistry 17: 9042–9046.
[56]
Bing T, Yang X, Mei H, Cao Z, Shangguan D (2010) Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg Med Chem 18: 1798–1805.
